At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
PTNS treatment +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation
In Brief
A clinical study evaluating PTNS treatment and Sham treatment for Overactive Bladder. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The aim of this study is to determine the efficacy of an accelerated course for percutaneous tibial nerve stimulation (PTNS) induction to treat overactive bladder symptoms. The standard 12 weekly induction treatments may be a patient burden and a more rapid induction may speed up symptomatic improvement.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOveractive Bladder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartMar 2018
First PostedJun 2018
Primary CompletionMay 2022
Study CompletionNov 2022
TodayJul 2026
First PostedJun 6, 2018
Enrollment StartMar 13, 2018
Primary CompletionMay 12, 2022
Study CompletionNov 17, 2022
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 8.1 years ago
Interventions
PTNS treatmentdevice
One-week induction consisting of three active PTNS treatments, each 2 hours long
Sham treatmentdevice
One-week induction consisting of three active PTNS treatments, each 2 hours long